Sign In   |   Register

 

Breaking News:

Breaking News

1-15-19 Canbiola, Inc. (CANB)
Senator Ronald A. Silver Joins Canbiola, Inc. Corporate Advisory Board

Read Complete Press Release>>

Greenridge Global Equity Research
Issues Updates 1-10-19
Guangdong Land Holdings, Ltd.
Click Here>>

1-9-19 Canbiola, Inc. (CANB)
Canbiola, Inc. has Purchased Pure Health Products LLC and is Launching Pure Leaf Oil as its Consumer Brand

Read Complete Press Release>>

1-4-19 Endurance Exploration Group, Inc. (EXPL)
Endurance Exploration Group, Inc.
Files
Form 15 to Terminate SEC Reporting Obligations

Click Here>>

Greenridge Global Equity Research
Issues Updates 11-6-18
Fullshare Holdings, Ltd.
Click Here>>

11-07-18 Trickle Research Initiates Research of
Alvopetro Energy, Ltd
12-24 Month Price Target $1.10

Click Here for Research Report

Trickle Research Earnings Update 11-13-18
Command Center, Inc. (CCNI)
12-24 Month Target Price $8.75

Click Here for Report

11-15-18
Canbiola, Inc. (CANB)

Canbiola, Inc. Uplists to OTCQB Venture Market.

Read Complete Press Release

Greenridge Global Equity Research
Issues Updates 11-2-18
Guangdong Land Holdings, Ltd.
Click Here>>

10-29 Mining Magazine

Could technology open doors to a cleaner-burning future for
coal? Clean Coal Technologies and the University of Wyoming are
collaborating on a cleaner, more efficient way for the US and the
world to produce and consume coal
Click Here for complete Article


Trickle Research issues update of
AzurRx Biopharma, Inc.  10-16-18
12-24 Month Price Target $10.25

Click Here for Update Report

10-11-18 Summit Wireless Technologies, Inc. (WISA)
Announces
Certification of Axiim Link
WiSA USB Transmitter
Read Complete Release

10-10-18 Ascendiant Capital markets, LLC
Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
  Buy Rating and Price Target $7.00

Click Here for Research Report

09-28-18 Trickle Research Initiates Research of
Summit Wireless Technologies, Inc. (WISA) 
12-24 Month Price Target $9.25

Click Here for Research Report

10-3-18, Endurance Exploration Group, Inc. (“EXPL”)

operating through its previously announced joint venture, Swordfish
Partners (the “Joint Venture”), is pleased to announce that
it has acquired title to over 600 items and artifacts
salvaged from the Steamship Pulaski.

 

10-1-18, Endurance Exploration Group, Inc. (“EXPL”) through a newly formed entity (or, “Affiliate”), has entered into a joint-venture with Global Marine Archaeological Research, LLC.  (“GMAR”)

Click Here

9-24-18 Trickle Research Issues Research Note
AzurRx Biopharma, Inc.
12-24 Month Price Target $10.25

Click Here for Research Note

8-23-18 Trickle Research Issues Earnings Update
PetroShare Corp 
12-24 Month Price Target $3.20

Click Here for Research Note

8-15-18 Trickle Research Issues Research Note
Command Center, Inc.  
12-24 Month Price Target $9.60

Click Here for Research Note

8-16-18 Trickle Research Issues Research Note
Social Reality, Inc.  
12-24 Month Price Target $8.50

Click Here for Research Note

Consilium Global Research Issues
Quarterly Update 8-7-18
Zynex, Inc. 
Price Target $7.00
    Click Here>>

8-1-18 Trickle Research Issues Research Note
Social Reality, Inc. 
12-24 Month Price Target $7.50

Click Here for Research Note

05-31-18 Trickle Research Initiates Research of
Petroshare Corp 
12-24 Month Price Target $3.20

Click Here for Research Report





 

  Black Swan Research
Research Coverage 7-18
SMM is now hosting Equity Research and updates from top tier research providers:           
   Catalyst Research  
 Trickle Research
Click here to Subscribe to Trickle Research 
 Falcon Strategic Research
 Consilium Global Research
 ValuEngine
 Click Here to Subscribe to Black Swan Research
              

Black Swan Newsletter

SUBSCRIBE TO THE NEWSLETTER BELOW






 

December 2018

Click here to view

Our goal with the Black Swan Connection is to provide our subscribers, investors and financial professional compatriots outstanding investment insight that is a step above and outside of what will normally be found in mainstream financial press. To that end we have brought together seasoned, successful, and some of the brightest professionals in their respective fields to provide the articles and advice that is based on decades of practice in the field.

 

Feature Article

Are you Conflicted? I sure Am.
By: Dave Lavigne
November 2018

Things I Saw on My Trip to L.A.

By: Dave Lavigne, Trickle Research

December 2018

A few months ago, I provided some information regarding some upcoming microcap conferences that I thought were worth attending. The largest of those I referenced, my friend Chris Lahiji’s “LD Micro Conference”, was held in Los Angeles last week.  For those who have never attended, LD Micro features approximately 240 companies presenting on 5 tracks over three days. It can be a bit overwhelming.  To put that into perspective, I saw 50 presentations during my attendance.  That is tough duty for someone with a short attention span.  I thought there were some interesting presentations, so I will touch on a handful of those, and there were also some “macro” themes that I thought were interesting.  I will start with the macro piece.
Read Complete Article

Breaking News

Echelon Wealth Partners
Research Update 11-11-18
Antibe Therapeutics (TSXV-ATE)
Speculative Buy Target Price $1.40

Event: Ontario-based drug developer Antibe Therapeutics reported FQ219 financial data for the Sept-end quarter that met our expectations on most income statement metrics and on development timelines for flagship hydrogen sulfide-releasing naproxen analog ATB-346, as we will describe below. Bottom line:We are maintaining our Speculative BUY rating and $1.40 PT on ATE, with our valuation still based on NPV (40% discount rate) and multiples of our F2025 adjusted EBITDA/EPS forecasts ($165.6M/$0.41, respectively), with both profitability metrics driven by our expectations that ATB-346 can perform well in future Phase III knee osteoarthritis pain studies and that pending performance in the soon-to-commence 200-250-patient Phase II knee osteoarthritis will be sufficiently positive on key efficacy measures (WOMAC-based pain relief with simultaneous reduction in incidence/severity of gastroduodenal ulcers) to justify advancing into future pivotal studies and to support FDA approval/launch and “partnerability”. At current levels, our PT corresponds to a one-year return of 418%.
Read Complete Report

*Echelon is a leading independent, Canadian-owned and operated wealth management and capital markets firm. While SMM has no relationship with Echelon and is not being compensated for distribution of these research reports, Owners of SMM are significant shareholders in Antibe Holding which in turn has a significant interest in Antibe Therapeutics, Inc.

Trickle Research
Earnings Update 12-3-18
Summit Wireless Technologies, Inc. (WISA)
12-24 Month Target Price $9.25

There is not a great deal to update here since we just initiated the coverage near the end of this reporting period. As we noted in the initial coverage, we are not expecting much from the numbers for the second half, which of curse includes this reporting period and the one we are currently in. For what it is worth, the numbers were largely in lie. SG&A was a bit higher than we anticipated, but given the IPO in the quarter, as well as several other restructuring items (debt conversions etc.), we suspect that line item was particularly extraordinary.
Click Here for Report

Trickle Research Earnings Update 11-28-18
Social Reality, Inc. (SRAX)
12-24 Month Target Price $8.50

SRAX reported their 3QF18 results the other day, but with the holiday stuck between here and there, we are just catching up. Frankly there were no surprises of note. Recall, in some of our prior writings, we noted that the SRAXmd sale would “muddy” the Q3 numbers with extraordinary items. As it turned out, the numbers included about 37 days of SRAXmd contributions, which added to the extraordinariness. O
Click Here for Report
 

Trickle Research Earnings Update 11-13-18
Command Center, Inc. (CCNI)
12-24 Month Target Price $8.75

We have been covering CCNI for some time now, and we must admit, we seem to have a hard time nailing down the numbers one quarter to the next. After last quarter, we noted that we were “paring back some of our estimates just to try to get them more in line with the results over the past few quarters where revenue comps have been flat”. However, as it turned out, they reported revenues of $26.3 million which was just over $760,000 or about 3% higher than our revised estimate. The $26.3 million was about ½ way between the Q1 estimate we revised down, and the new number we revised down to.
Click Here for Report

InvestorsHub News Wire:

 

 

 

Weekly Update: January 8th, 2019

Latest Happenings

January 2nd, 2019 by Laura Anthony, Esq.

Regulation A+ Now Available For Publicly Reporting Companies

On December 19, 2018, the SEC adopted final rules allowing reporting companies to Rely on Regulation A to conduct securities offerings. On May 24, 2018, President Trump signed the Economic Growth, Regulatory Relief and Consumer Protection Act (the “Act”) into law requiring the SEC to amend Regulation A to allow for its use by Exchange Act reporting companies. Since that time, the marketplace has been waiting, somewhat impatiently, for the final rule change to be implemented.

Section 508 of the Act directed the SEC to amend Regulation A to remove the provision making companies subject to the SEC Securities Exchange Act reporting requirements ineligible to use the offering exemption and to add a provision such that a company’s Exchange Act reporting obligations will satisfy Regulation A+ reporting requirements.

Read Complete Article

 

ELIO Motors

A case of dumb and dumber…..

“Dumb” the poor sots that paid a deposit for one of these cars believing that they could really be built for $7,500 and “Dumber”… the real nuts who keep buying the stock and propping up the inevitable slide to zero.

Google Elio Motors and what do you get :

Search Results

Web results   

Elio Motors | The next big thing in transportation!

https://www.eliomotors.com/

Elio is more than a car. It's a mission. Our goal is to revolutionize American transportation. We're creating the ultimate commuter vehicle for virtually every budget ...

Gallery · ‎News · ‎Elio Motors · ‎Blogs


People also ask

Is the Elio ever coming out?                  No

Will Elio Motors ever make a car?          No

Will the Elio ever get built?                   No

How much does a 3 wheel car cost?      About $10,000 more than Elio claims he can sell it for

When can I buy an Elio?                       Never

What does the name Elio mean?           Name of jerk who started company and ripped the public for hundreds of millions

SEE MY ANSWERS ABOVE IN RED

Bottom line is that this still headed to zero-


The Biggest Mistake in Automotive History, Elio Motors

Check out this video

Says it all..

Stock is $2.80 and will be zero at some point…..

 

1-8-19
Canbiola, Inc. (CANB)
Canbiola, Inc. has Purchased Pure Health Products LLC and is Launching Pure Leaf Oil as its Consumer Brand

HICKSVILLE, NY, Jan. 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. (OTCQB: CANB) has purchased Pure Health Products LLC and is launching Pure Leaf Oil as its consumer brand. 

Due to strong product demand, Canbiola is on the path toward significant revenue growth in additional segments of the CBD industry.  While the Canbiola brand is synonymous with Medical Offices and our Doctor affiliate program, the company has launched Pure Leaf Oil targeting retail markets including c-stores, bodegas, and yes, even donut stores and bakeries through its network of distributors. Pure Leaf Oil is also expected to be sold through various leading online e-commerce platforms at very aggressive prices.

Read Complete Press Release

Endurance Exploration Group, Inc. (EXPL)
Press Release 1-4-19

Endurance Exploration Group, Inc. Files Form 15 to Terminate SEC Reporting Obligations

CLEARWATER, FL / ACCESSWIRE / January 4, 2019 / Endurance Exploration Group, Inc. (OTCQB: EXPL) (the "Company"), a company that specializes in historic shipwreck research, subsea survey and recovery of lost ships containing valuable cargoes, today announced that on January 3, 2019 it voluntarily filed a Form 15 with the United States Securities and Exchange Commission (the "Commission" or "SEC") to voluntarily deregister its common stock and suspend its reporting obligations under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company cited the significant cost, limited benefit and very limited trading of its stock as some of its reasons in taking this step. As a result of the filing of Form 15 with the Commission, the Company will no longer be required to file certain reports under the Exchange Act, including quarterly reports on Form 10-Q, annual reports on Form 10-K, and current reports on Form 8-K. Other filing requirements will terminate upon the effectiveness of the deregistration, which is expected to occur 90 days after the filing of the Form 15 with the Commission.
Click Here>>

 

Community Search
Sign In